Cannabis Stocks to Watch After FDA
Comments
March 4, 2019 -- InvestorsHub NewsWire -- Microcap Speculators
-- Last week, FDA Commissioner, Scott Gottlieb, announced
plans to hold the first public meetings on the administration’s
outlook for regulation of CBD in April and offered a few hints at
his thinking on the issue. Many cannabis companies are
planning to launch food, drink and cosmetics lines that contain
CBD, a non-psychoactive ingredient in cannabis that is widely
believed to have wellness properties, but which has not been
subjected to the kind of research that has been conducted on THC,
the plant’s psychoactive ingredient.
While investors may be turned off by of some companies in the
sector, ancillary plays like CleanSpark, Inc. (USOTC:
CLSK) and their microgrid power solution for the
cannabis industry that cuts the monthly electricity bill of indoor
grow-houses by up to 82%, may be a good option to research.
The company is not fully exposed to cannabis, as most of their
revenue is driven from operations unrelated to cannabis. The
company has been ranked in the top 10 microgrids by Navigant
Research.
Today we are highlighting: CleanSpark, Inc. (USOTC:
CLSK), Aurora Cannabis, Inc. (NYSE:
ACB), Tilray, Inc. (NASDAQ:
TLRY), Cronos Group, Inc. (NASDAQ:
CRON) and Terra Tech Corp. (TRTC).
It’s been a busy few months for CleanSpark, Inc.
(USOTC:
CLSK) (Market Cap: $172.600M, Share Price:
$4.16). CLSK has announced an up to $18 million
deal with NYSE company MAC, which has completed an acquisition
adding $3.6 million in gross sales to CLSK’s bottom line
during early 2019 alone and several other achievements that have
brought this microgrid growth play well off its $1.10 52-week
low.
The company counts itself as one of the very few OTC companies
on the LD Micro Index (only 4% of the 1000 companies are OTC
listed). The increase in exposure means investors should
research CLSK now.
_______
Aurora Cannabis, Inc. (NYSE:
ACB) (Market Cap: $7.035B, Share Price:
$7.34) reported that it had agreed to acquire a
majority stake in Portuguese company, Gaia Pharma Ltd., at an
undisclosed sum. The company is planning to establish a
medical cannabis production facility as well as for other related
products as the company expands its reach to Europe.
________
Tilray, Inc. (NASDAQ:
TLRY) (Market Cap: $7.523B, Share Price:
$79.51) acquired Manitoba
Harvest from Compass Diversified Holdings (CODI).
The C$419 million purchase price consists of cash and Class 2
common stock shares of Tilray.
________
Cronos Group, Inc. (NASDAQ:
CRON) (Market Cap: $3.242B, Share Price:
$21.71) announced in early December that it had
entered into a subscription agreement with Altria Group, Inc., one
of the leading tobacco brands in the world, pursuant to which
Altria agreed to make an approximately C$2.4 billion equity
investment in Cronos Group on a private placement basis in exchange
for common shares in the capital of the company.
_______
Terra Tech Corp. (TRTC) (Market Cap:
$81.775M, Share Price: $0.88) announced the company
has agreed to acquire the remaining stake in the Blüm Reno
dispensary in Nevada. Under the agreement, Terra Tech will increase
its stake in the Reno, Nev.-based dispensary to 100% from 50%. The
acquisition includes the Blüm dispensary’s cannabis licenses as
well.
Legal Disclaimer:
This article was written by Regal Consulting, LLC (“Regal
Consulting”). Regal Consulting has agreed to a three-month
term consulting agreement with CLSK dated 9/12/18. The
agreement calls for $10,000 in cash, and 30,000 restricted 144
shares of CLSK per month. Regal and CLSK have signed an amendment
to extend the contract for twelve months starting 10/10/18, and
increased the cash component to $20,000 per month. CLSK has
paid an additional $12,000 for services provided in November. CLSK
has paid an additional $88,000 for services provided in December.
CLSK has paid an additional $100,000 for services for
January. CLSK has paid an additional $80,000 for services for
February. Regal was paid an additional $30,000 for March services
and possibly compensated more for March in the future, at which
time Regal will update this disclaimer. All payments were made
directly by Clean Spark, Inc. to Regal Consulting, LLC. to provide
investor relations services, of which this article is a part of.
Regal Consulting also paid one thousand dollars cash to
microcapspeculators.com to distribute this article. Regal
Consulting may have a position in the securities mentioned in this
article at the time of publication, and may increase or decrease
its position without notice. This article is based on public
information and the opinions of Regal Consulting. CLSK was given an
opportunity to edit this article. This article contains
forward-looking statements that are subject to certain risks and
uncertainties that could cause actual results to differ materially
from any results predicted herein. Regal Consulting is not
registered with any financial or securities regulatory authority,
and does not provide or claim to provide investment advice.
http://www.regalconsultingllc.com/full
legal disclaimer/
Microspeculators.com Full Legal Disclaimer Click Here.
Contact Information:
Company Name: Microcap Speculators
Contact Person: Media Manager
Email: info@microcapspeculators.com
Phone: 1-702-720-6310
Country: United States
Website: http://microcapspeculators.com/
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cronos (NASDAQ:CRON)
Historical Stock Chart
From Apr 2023 to Apr 2024